Clinicopathological and survival analysis of Japanese patients with resected non-small-cell lung cancer harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA gene amplification

Journal of Thoracic Oncology

Volumn 10, Issue 11, 2015, Pages 1590-1600

  Inoue, Yusuke ^a   Matsuura, Shun ^a   Kurabe, Nobuya ^a   Kahyo, Tomoaki ^a   Mori, Hiroki ^b   Kawase, Akikazu ^a   Karayama, Masato ^a   Inui, Naoki ^a   Funai, Kazuhito ^a   Shinmura, Kazuya ^a   Suda, Takafumi ^a   Sugimura, Haruhiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

Coamplification; Gene amplification; NKX2 1; Non small cell lung cancer; SETDB1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HISTONE LYSINE METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE CATALYTIC SUBUNIT ALPHA; SCATTER FACTOR RECEPTOR; SETDB1 PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; COPY NUMBER VARIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR GENE; GENETICS; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE AMPLIFICATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 84945265819     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000685     Document Type: Article

References (50)

1. Qian J, Massion PP, Role of chromosome 3q amplification in lung cancer. J Thorac Oncol 2008 3 212 215
2. Tang X, Kadara H, Behrens C, Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis. Clin Cancer Res 2011 17 2434 2443
3. Barletta JA, Perner S, Iafrate AJ, Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. J Cell Mol Med 2009 13 1977 1986
4. Perner S, Wagner PL, Soltermann A, TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 2009 217 65 72
5. Lee JS, Kim HR, Lee CY, EGFR and TTF-1 gene amplification in surgically resected lung adenocarcinomas: clinicopathologic significance and effect on response to EGFR-Tyrosine kinase inhibitors in recurred cases. Ann Surg Oncol 2013 20 3015 3022
6. Cappuzzo F, Marchetti A, Skokan M, Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. J Clin Oncol 2009 27 1667 1674
7. Cappuzzo F, Jänne PA, Skokan M, MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. Ann Oncol 2009 20 298 304
8. Beau-Faller M, Ruppert AM, Voegeli AC, MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort. J Thorac Oncol 2008 3 331 339
9. Heinmöller P, Gross C, Beyser K, HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin. Clin Cancer Res 2003 9 5238 5243
10. Hirsch FR, Varella-Garcia M, Franklin WA, Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas. Br J Cancer 2002 86 1449 1456
11. Pellegrini C, Falleni M, Marchetti A, HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry. Clin Cancer Res 2003 9 3645 3652
12. Wilbertz T, Wagner P, Petersen K, SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 2011 24 944 953
13. Toschi L, Finocchiaro G, Nguyen TT, Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease. PLoS One 2014 9 e95303
14. Kim HR, Kim DJ, Kang DR, Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. J Clin Oncol 2013 31 731 737
15. Cihoric N, Savic S, Schneider S, Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer. Br J Cancer 2014 110 2914 2922
16. Okudela K, Suzuki M, Kageyama S, PIK3CA mutation and amplification in human lung cancer. Pathol Int 2007 57 664 671
17. Kawano O, Sasaki H, Okuda K, PIK3CA gene amplification in Japanese non-small cell lung cancer. Lung Cancer 2007 58 159 160
18. Rodriguez-Paredes M, Martinez de Paz A, Simó-Riudalbas L, Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene 2014 33 2807 2813
19. Sugimura H, Detection of chromosome changes in pathology archives: an application of microwave-Assisted fluorescence in situ hybridization to human carcinogenesis studies. Carcinogenesis 2008 29 681 687
20. Kiyose S, Nagura K, Tao H, Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization. Pathol Int 2012 62 477 484
21. Kanda Y, Investigation of the freely available easy-To-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013 48 452 458
22. Bass AJ, Watanabe H, Mermel CH, SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009 41 1238 1242
23. Massion PP, Kuo WL, Stokoe D, Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res 2002 62 3636 3640
24. Dutt A, Ramos AH, Hammerman PS, Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS One 2011 6 e20351
25. Gainor JF, Varghese AM, Ou SH, ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer. Clin Cancer Res 2013 19 4273 4281
26. Gray JW, Collins C, Genome changes and gene expression in human solid tumors. Carcinogenesis 2000 21 443 452
27. Weiss J, Sos ML, Seidel D, Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2010 2 62ra93
28. Mass RD, Press MF, Anderson S, Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin Breast Cancer 2005 6 240 246
29. Gomez-Martin C, Plaza JC, Pazo-Cid R, Level of HER2 gene amplification predicts response and overall survival in HER2-positive advanced gastric cancer treated with trastuzumab. J Clin Oncol 2013 31 4445 4452
30. Watanabe Y, Ikemura T, Sugimura H, Amplicons on human chromosome 11q are located in the early/late-switch regions of replication timing. Genomics 2004 84 796 805
31. Sano T, Kitayama Y, Igarashi H, Chromosomal numerical abnormalities in early stage lung adenocarcinoma. Pathol Int 2006 56 117 125
32. Matsuura S, Kahyo T, Shinmura K, SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers. Sci Rep 2013 3 3012
33. Weir BA, Woo MS, Getz G, Characterizing the cancer genome in lung adenocarcinoma. Nature 2007 450 893 898
34. Kendall J, Liu Q, Bakleh A, Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A 2007 104 16663 16668
35. Kwei KA, Kim YH, Girard L, Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 2008 27 3635 3640
36. Saito RA, Watabe T, Horiguchi K, Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-To-mesenchymal transition in lung adenocarcinoma cells. Cancer Res 2009 69 2783 2791
37. Winslow MM, Dayton TL, Verhaak RG, Suppression of lung adenocarcinoma progression by Nkx2-1. Nature 2011 473 101 104
38. Anagnostou VK, Syrigos KN, Bepler G, Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma. J Clin Oncol 2009 27 271 278
39. Harte PJ, Wu W, Carrasquillo MM, Matera AG, Assignment of a novel bifurcated SET domain gene, SETDB1, to human chromosome band 1q21 by in situ hybridization and radiation hybrids. Cytogenet Cell Genet 1999 84 83 86
40. Ceol CJ, Houvras Y, Jane-Valbuena J, The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 2011 471 513 517
41. Yu HA, Arcila ME, Rekhtman N, Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clin Cancer Res 2013 19 2240 2247
42. Dziadziuszko R, Wynes MW, Singh S, Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer. J Thorac Oncol 2012 7 340 347
43. Cappuzzo F, Varella-Garcia M, Shigematsu H, Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol 2005 23 5007 5018
44. Suzuki M, Shiraishi K, Yoshida A, HER2 gene mutations in non-small cell lung carcinomas: concurrence with Her2 gene amplification and Her2 protein expression and phosphorylation. Lung Cancer 2015 87 14 22
45. Tran TN, Selinger CI, Kohonen-Corish MR, Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer. Lung Cancer 2013 81 462 467
46. Jiang T, Gao G, Fan G, FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-Analysis. Lung Cancer 2015 87 1 7
47. Pelosi G, Del Curto B, Trubia M, 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study. Clin Cancer Res 2007 13 1995 2004
48. McCaughan F, Pole JC, Bankier AT, Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med 2010 182 83 91
49. Hussenet T, du Manoir S, SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 2010 9 1480 1486
50. Lu Y, Futtner C, Rock JR, Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One 2010 5 e11022